4//SEC Filing
Hansard Adam 4
Accession 0001209191-22-044460
CIK 0001697532other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 8:35 PM ET
Size
27.7 KB
Accession
0001209191-22-044460
Insider Transaction Report
Form 4
Hansard Adam
Chief Commercial Officer
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+50,000→ 50,000 totalExercise: $1.05Exp: 2032-04-13→ Common Stock (50,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+21,100→ 21,100 totalExercise: $1.05Exp: 2032-01-07→ Common Stock (21,100 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−21,100→ 0 totalExercise: $9.44Exp: 2031-12-14→ Common Stock (21,100 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+21,100→ 21,100 totalExercise: $1.05Exp: 2031-12-14→ Common Stock (21,100 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−50,000→ 0 totalExercise: $2.02Exp: 2032-04-13→ Common Stock (50,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−21,100→ 0 totalExercise: $4.17Exp: 2032-01-07→ Common Stock (21,100 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+32,339→ 32,339 totalExercise: $1.05Exp: 2030-12-10→ Common Stock (32,339 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−32,339→ 0 totalExercise: $23.15Exp: 2030-12-10→ Common Stock (32,339 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−104,665→ 0 totalExercise: $34.28Exp: 2030-03-09→ Common Stock (104,665 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+104,665→ 104,665 totalExercise: $1.05Exp: 2030-03-09→ Common Stock (104,665 underlying)
Footnotes (6)
- [F1]The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.
- [F2]Reflects an initial grant of 50,000 Options granted on April 13, 2022 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on April 13, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
- [F3]Reflects an initial grant of 21,100 Options granted on January 7, 2022 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on January 7, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
- [F4]Reflects an initial grant of 21,100 Options granted on December 14, 2021 that vests as follows: One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on December 14, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
- [F5]Reflects an initial grant of 81,700 Options granted on March 9, 2020 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on December 10, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
- [F6]Reflects an initial grant of 179,425 Options granted on March 9, 2020 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on March 9, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
Documents
Issuer
Applied Therapeutics Inc.
CIK 0001697532
Entity typeother
Related Parties
1- filerCIK 0001805556
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 8:35 PM ET
- Size
- 27.7 KB